Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,200
Closed -$1.09M 4005
2025
Q3
$1.09M Buy
16,200
+1,100
+7% +$73K ﹤0.01% 1670
2025
Q2
$984K Buy
+15,100
New +$905K ﹤0.01% 1564
2023
Q1
Sell
-6,700
Closed -$501K 2370
2022
Q4
$501K Hold
6,700
﹤0.01% 1150
2022
Q3
$432K Hold
6,700
﹤0.01% 1189
2022
Q2
$464K Buy
+6,700
New +$497K ﹤0.01% 1201
2018
Q3
Sell
-300,000
Closed -$11.9M 1087
2018
Q2
$11.9M Buy
+300,000
New +$11.5M 0.05% 403
2016
Q3
Sell
-55,500
Closed -$1.92M 774
2016
Q2
$1.92M Buy
+55,500
New +$1.92M 0.01% 571

Other funds holding HOLX

Steven Cohen's HOLX Position: Q2 2026 in Review

Steven Cohen sold out of Hologic (HOLX) in Q2 2026, closing a stake of 71,776 shares — an estimated $5.43M sold.

Steven Cohen first reported a position in HOLX in Q3 2015 and held it in 28 quarters. The position peaked at $132M in Q3 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Steven Cohen reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 71,776 Hologic shares in Q2 2026, an estimated $5.43M.
  • Steven Cohen first reported a position in Hologic in Q3 2015 and held it in 28 quarters.
  • Steven Cohen's Hologic position peaked at $132M in Q3 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.